Identification of Urinary Biomarkers Related to Cisplatin-Induced Acute Renal Toxicity Using NMR-Based Metabolomics
![]() ![]() |
Wen, He
(Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University)
Yang, Hye-Ji (Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University) Choi, Myung-Joo (Department of Biomedical Sciences, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University) Kwon, Hyuk-Nam (Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University) Kim, Min-Ah (Department of Biomedical Sciences, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University) Hong, Soon-Sun (Department of Biomedical Sciences, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University) Park, Sung-Hyouk (Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University) |
1 | Wen, H., Kang, S., Song, Y., Sung, S. H. and Park, S. (2010a) Differentiation of cultivation sources of Ganoderma lucidum by NMR-based metabolomics approach. Phytochem. Anal. 21, 73-79. DOI |
2 | Wen, H., Yoo, S. S., Kang, J., Kim, H. G., Park, J. S., Jeong, S., Lee, J. I., Kwon, H. N., Kang, S., Lee, D. H. and Park, S. (2010b) A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J. Hepatol. 52, 228-233. DOI |
3 | Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T. and Trygg, J. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class Models. Anal. Chem. 80, 115-122. DOI |
4 | Wishart, D. S. (2005) Metabolomics: the principles and potential applications to transplantation. Am. J. Transplant. 5, 2814-2820. DOI |
5 | Yao, X., Panichpisal, K., Kurtzman, N. and Nugent, K. (2007) Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 334, 115-124. DOI |
6 | Portilla, D., Li, S., Nagothu, K. K., Megyesi, J., Kaissling, B., Schnackenberg, L., Safi rstein, R. L. and Beger, R. D. (2006) Metabolomic study of cisplatin-induced nephrotoxicity. Kidney International 69, 2194-2204. DOI |
7 | Pruefer, F. G., Lizarraga, F., Maldonado, V. and Melendez-Zajgla, J. (2008) Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J. Chemother. 20, 348-354. DOI |
8 | Rozen, R., Tenenhouse, H. S. and Scriver, C. R. (1979). Taurine transport in renal brush-border-membrane vesicles. Biochem. J. 180, 245-248. |
9 | Sands, C. J., Coen, M., Maher, A. D., Ebbels, T. M., Holmes, E., Lindon, J. C. and Nicholson, J. K. (2009) Statistical total correlation spectroscopy editing of 1H NMR spectra of biofl uids: application to drug metabolite profi le identifi cation and enhanced information recovery. Anal. Chem. 81, 6458-6466. DOI |
10 | Smith, I. E. and Talbot, D. C. (1992) Cisplatin and its analogues in the treatment of advanced breast cancer: a review. Br. J. Cancer 65, 787-793. DOI |
11 | Kang, J., Choi, M. Y., Kang, S., Kwon, H. N., Wen, H., Lee, C. H., Park, M., Wiklund, S., Kim, H. J., Kwon, S. W. and Park, S. (2008a) Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an effi cient tool for discriminating between Korean and Chinese herbal medicines. J. Agric. Food Chem. 56, 11589-11595. DOI |
12 | Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C. and Chinnaiyan, A. M. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 457, 910-914. DOI |
13 | Trygg, J. and Wold, S. (2002) Orthogonal projections to latent structures (O-PLS). J. Chemom. 16, 119-128. DOI |
14 | von der Maase, H., Hansen, S. W., Roberts, J. T., Dogliotti, L., Oliver, T., Moore, M. J., Bodrogi, I., Albers, P., Knuth, A., Lippert, C. M., Kerbrat, P., Sanchez Rovira, P., Wersall, P., Cleall, S. P., Roychowdhury, D. F., Tomlin, I., Visseren-Grul, C. M. and Conte, P. F. (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J. Clin. Oncol. 18, 3068-3077. |
15 | Kang, J., Lee, S., Kang, S., Kwon, H. N., Park, J. H., Kwon, S. W. and Park, S. (2008b) NMR-based metabolomics approach for the differentiation of ginseng (Panax ginseng) roots from different origins. Arch. Pharm. Res. 31, 330-336. DOI |
16 | Loehrer, P. J. and Einhorn, L. H. (1984) Drugs five years later. Cisplatin. Ann. Intern. Med. 100, 704-713. DOI ScienceOn |
17 | Nicholson, J. K., Connelly, J., Lindon, J. C. and Holmes, E. (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153-161. DOI |
18 | Maher, A. D., Cloarec, O., Patki, P., Craggs, M., Holmes, E., Lindon, J. C. and Nicholson, J. K. (2009) Dynamic biochemical information recovery in spontaneous human seminal fl uid reactions via 1H NMR kinetic statistical total correlation spectroscopy. Anal. Chem. 81, 288-295. DOI |
19 | Maxuitenko, Y. Y., North, W. G. and Roebuck, B. D. (1997) Urinary taurine as a non-invasive marker of afl atoxin B1-induced hepatotoxicity: success and failure. Toxicology 118, 159-169. DOI |
20 | Muggia, F. (2009) Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol. Oncol. 112, 275-281. DOI ScienceOn |
21 | Nicholson, J. K., Lindon, J. C. and Holmes, E. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29, 1181-1189. DOI |
22 | Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. and Nicholson, J. K. (2009) Pharmacometabonomic identifi cation of a signifi cant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA. 106, 14728-14733. DOI |
23 | Clayton, T. A., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J. P., Le Net, J. L., Baker, D., Walley, R. J., Everett, J. R. and Nicholson, J. K. (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440, 1073-1077. DOI |
24 | Ebbels, T. M., Keun, H. C., Beckonert, O. P., Bollard, M. E., Lindon, J. C., Holmes, E. and Nicholson, J. K. (2007) Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome. Res. 6, 4407-4422. DOI |
25 | Cloarec, O., Dumas, M. E., Craig, A., Barton, R. H., Trygg, J., Hudson, J., Blancher, C., Gauguier, D., Lindon, J. C., Holmes, E. and Nicholson, J. (2005) Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identifi cation from metabolic 1H NMR data sets. Anal. Chem. 77, 1282-1289. DOI |
26 | Crino, L., Calandri, C., Maestri, A. and Marrocolo, F. (2001) Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer. Oncology (Williston Park) 15, 40-42. |
27 | Davis, J. W. and Kramer, J. A. (2006) Genomic-based biomarkers of drug-induced nephrotoxicity. Expert Opin. Drug Metab. Toxicol. 2, 95-101. DOI |
28 | Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G. Jr., Levrero, M. and Wang, J. Y. (1999) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399, 806-809. DOI |
29 | Hewitt, S. M., Dear, J. and Star, R. A. (2004) Discovery of protein biomarkers for renal diseases. J. Am. Soc. Nephrol. 15, 1677-1689. DOI |
30 | Arany, I. and Safi rstein, R. L. (2003) Cisplatin nephrotoxicity. Semin. Nephrol. 23, 460-464. DOI |
31 | Boudonck, K. J., Mitchell, M. W., Nemet, L., Keresztes, L., Nyska, A., Shinar, D. and Rosenstock, M. (2009) Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol. Pathol. 37, 280-292. DOI |
32 | Bylesjo, M., Rantalainen, M., Cloarec, O., Nicholson, J., Holmes, E. and Trygg, J. (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classifi cation. J. Chemom. 20, 341-351. DOI |
![]() |